Proposal for a multidisciplinary approach to the patient with morbid obesity: The St. Franciscus Hospital Morbid Obesity Program

European Journal of Internal Medicine

Volumn 19, Issue 2, 2008, Pages 92-98

  Elte, J W F ^a   Castro Cabezas, M ^a   Vrijland, W W ^a   Ruseler, C H ^a   Groen, M ^a   Mannaerts, G H H ^a  

^a SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Bariatric surgery; Cardiovascular disease; Diet; Protocol; Risk factor; Team

Indexed keywords

GHRELIN; LEPTIN; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

BARIATRIC SURGERY; BEHAVIOR MODIFICATION; BINGE EATING DISORDER; BODY MASS; CALORIC RESTRICTION; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COMORBIDITY; ENERGY EXPENDITURE; HEALTH CARE COST; HEALTH EDUCATION; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; OBESITY; PATIENT REFERRAL; PHYSICAL ACTIVITY; POSTOPERATIVE PERIOD; REVIEW; STOMACH BYPASS; WEIGHT REDUCTION;

ANTI-OBESITY AGENTS; BARIATRIC SURGERY; COMBINED MODALITY THERAPY; COMORBIDITY; HUMANS; INTERDISCIPLINARY COMMUNICATION; LIFE STYLE; NETHERLANDS; OBESITY, MORBID; REFERRAL AND CONSULTATION; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 38749099791     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.06.015     Document Type: Review

References (39)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
2. Bender R., Trautner C., Spraul M., and Berger M. Assessment of excess mortality in obesity. Am J Epidemiol 147 (1998) 42-48
3. Melissas J., Chistodoulakis M., Spyridakis M., et al. Disorders associated with clinically severe obesity: significant improvement after surgical weight reduction. South Med J 91 (1998) 1143-1148
4. Wolf A.M., Beisiegel U., Kortner B., and Kuhlmann H.W. Does gastric bypass restriction surgery reduce the risk of metabolic diseases?. Obes Surg 8 (1998) 9-13
5. Wadden T.A., Sarwer D.B., Womble L.G., Foster G.D., McGuckin B.G., Schimmel A., et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 81 (2001) 1001-1024
6. Gibbons L.M., Sarwer D.B., Crerand C.E., Fabricatore A.N., Kuehnel R.H., Lipschutz P.E., et al. Previous weight loss experiences of bariatric surgery candidates: how much have patients dieted prior to surgery?. Surg Obes Rel Dis 2 (2006) 159-164
7. Bennett J.M., Mehta S., and Rhodes M. Surgery for morbid obesity. Postgrad Med J 83 (2007) 8-15
8. Leibel R.L., Rosenbaum M., and Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 332 (1995) 621-628
9. Brolin R.E. Bariatric surgery and long-term control of morbid obesity. JAMA 288 (2002) 2793-2796
10. Buchwald H., Avidor Y., Braunwald E., Jensen M.D., Pories W., Fahrbach K., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737
11. Maggard M.A., Shugarman L.R., Suttorp M., Maglione M., Sugerman H.J., Livingston E.H., et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 142 (2005) 547-559
12. Sjöström L., Lindroos A.K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2693
13. Christou N.V., Sampalis J.S., Liberman M., Look D., Auger S., McLean A.P.H., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240 (2004) 416-424
14. Weijgert van de E.J., Ruseler C.H., and Elte J.W.F. Long-term follow-up after gastric surgery for morbid obesity: preoperative weight loss improves the long-term control of morbid obesity after vertical banded gastroplasty. Obes Surg 9 (1999) 426-432
15. Howard A.N. The historical development, efficacy, and safety of very-low-calorie diets. Int J Obes 5 (1981) 195-208
16. Finer N. Obesity. Clin Med 3 (2003) 23-27
17. Padjwal R.S., and Majumdar S.R. Drug treatment for obesity: orlistat, sibutramine, and rimonabant. Lancet 369 (2007) 71-77
18. Ruseler C.H., Elte J.W.F., Groen M., and Scheltema E.V. De chirurgische behandeling van morbide obesitas; resultaten en complicaties bij 200 patiënten. In: Bulens C., et al. (Ed). In dienst van broeder ezel (1992) 153-159
19. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334 (1996) 292-295
20. Blum W.F. Leptin: the voice of the adipose tissue. Horm Res 48 suppl 4 (1997) 2-8
21. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma Ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
22. Roux le C.W., Aylwin S.J.B., Batterham R.L., Borg C.M., Coyle F., Prasad V., et al. Gut hormones profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243 (2006) 108-114
23. Jefferey R.W., Kelly K.M., Rothman A.J., Sherwood N.E., and Boutelle K.N. The weight loss experience: a descriptive analysis. Ann Behav Med 27 (2004) 100-106
24. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 115 (1991) 956-961
25. Stocker D.J. Management of the bariatric surgery patient. Endocrinol Metab Clin N Am 32 (2003) 437-457
26. Sauerland S., Angrisani L., Belachew M., Chevallier J.M., Favretti F., Finer N., et al. Obesity surgery. Evidence-based guidelines of the European Association for Endoscopic Surgery (E.A.E.S.). Surg Endosc 19 (2005) 200-221
27. Buchwald H. Bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg 200 (2005) 593-604
28. Fried M., Hainer V., Basdevant A., et al. Interdisciplinary European guidelines for surgery for sever (morbid) obesity. Obes Surg 17 (2007) 260-270
29. Dzator J.A., Hendrie D., Burke V., Gianguilio N., Gillam H.F., Beilin L.J., et al. A randomized trial of interactive group sessions achieved greater improvements in nutrition and physical activity at a tiny increase in cost. J Clin Epidemiol 57 (2004) 610-619
30. Dixon J.B., and O'Brian P.E. Selecting the optimal patient for Lap-Band placement. Am J Surg 184 (2002) 17S-20S
31. Vallis T.M., Butler G.S., Perey B., Veldhuysen van Zanten S.J., MacDonald A.S., and Konok G. The role of psychological functioning in morbid obesity and its treatment with gastroplasty. Obes Surg 11 (2001) 716-725
32. Bocchieri L.E., Meana M., and Fisher B.L. A review of psychosocial outcomes of surgery for morbid obesity. J Psychiatr Res 52 (2002) 155-742
33. Herpertz S., Kielmann R., Wolf A.M., Langkafel M., Senf W., and Hebebrand J. Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes 27 (2003) 1300-1314
34. van Hout G.C.M., Leibbrandt A.J., Jakimowicz J.J., Smulders J.F., Schoon E.J., van Spreeuwel J.P., et al. Bariatric surgery and bariatric psychology: general overview and the Dutch approach. Obes Surg 13 (2003) 926-931
35. Sugerman H.J., Starkey J.V., and Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 205 (1987) 613-624
36. Chapman A.E., Kiroff G., Game P., Foster B., O'Brien P., Ham J., et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 103 (2004) 326-351
37. Jazet I.M., Groot de G.H., Tuijnebreyer W.E., Fogteloo A.J., Vandenbroucke J.P., and Meinders A.E. Cardiovascular risk factors after bariatric surgery: do patients gain more than expected from their substantial weight loss?. Eur J Int Med 18 (2007) 39-43
38. Mathus-Vliegen E.M., de Weerd S., and de Wit L.T. Health-related quality-of-life in patients with morbid obesity after gastric banding for surgically induced weight loss. Surgery 135 (2004) 489-497
39. Champault A., Duwat O., Polliand C., Rizk N., and Champault G.G. Quality of life after laparoscopic gastric banding. Prospective study (152 cases) with a follow-up of 2 years. Surg Laparosc Endosc Percutan Tech 16 (2006) 131-136